Agent for promoting corneal endothelial cell adhesion
AssigneesSenju Pharmaceutical Co., Ltd., Shigeru Kinoshita
InventorsNoriko Koizumi, Shigeru Kinoshita, Morio Ueno
Life of this patent
Estimating the term…
Abstract
The invention provides an agent for promoting adhesion of a corneal endothelial cell, containing a Rho kinase inhibitor, as well as a culture medium for a corneal endothelial cell, a solution for preservation of cornea, and a method of producing a corneal endothelial preparation, which includes culturing the corneal endothelial cell using the aforementioned culture medium.
Claims12
A method for treatment of a corneal endothelial dysfunction associated with intraocular surgery or trauma, comprising (i) identifying a subject currently suffering from the corneal endothelial dysfunction and (ii) administering an effective amount of a Rho kinase inhibitor to an eye of the subject to treat the corneal endothelial dysfunction in the eye of the subject.
Dependencies are inferred from the claim text.